Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	REGNRegeneron Pharmaceuticals	ARGXargenx SE	VRTXVertex Pharmaceuticals
Snapshot
Price	$849.21	$1045.23	$554.15
Market cap	$68.59B	$55.53B	$115.02B
Valuation
P/E	20.1x	26x	28.7x
Forward P/E	19.2x	18.6x	27x
Growth
Revenue growth	5.9%	80.6%	10.1%
EPS growth	4.4%	111.4%	6.1%
Profitability
Net margin	29.6%	48.2%	35.5%
ROE	14.3%	22.9%	23.9%
Balance sheet & cash
Debt / equity	0.09x	0.01x	0.01x
Free cash flow yield	6.3%	—	3.1%
Dividend yield	0.6%	—	—
Verdict
Investment rating	Favorable· 69	Strong· 88	Favorable· 67

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	REGNtoday $849	ARGXtoday $1045	VRTXtoday $554
2027	$664.93 – $975.23+15% CAGR	$1,657.37 – $2,430.81+133% CAGR	$441.05 – $646.87+17% CAGR
2028	$694.19 – $1,018.14+9% CAGR	$3,504.01 – $5,139.21+122% CAGR	$468.04 – $686.46+11% CAGR
2029	$724.73 – $1,062.94+8% CAGR	$7,408.18 – $10,865.33+118% CAGR	$496.68 – $728.47+10% CAGR
2030	$756.62 – $1,109.71+7% CAGR	$15,662.37 – $22,971.47+117% CAGR	$527.08 – $773.05+9% CAGR
2031	$789.91 – $1,158.54+6% CAGR	$33,113.38 – $48,566.29+115% CAGR	$559.34 – $820.36+8% CAGR
5-yr CAGR	-1.4% – 6.4%	99.6% – 115.5%	0.2% – 8.2%